Lactose monohydrate: Clinical Trials

13 trials of Lactose monohydrate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 terminated, 1 recruiting, 1 unknown. 6 Phase 3, 5 Phase 2, 2 Not applicable, 2 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Terminated 1, Unknown 1
Phase 25Completed 4, Terminated 1
Not applicable2Completed 1, Recruiting 1
Phase 12Completed 1, Withdrawn 1
Early Phase 11Completed 1
Phase 41Terminated 1

Follow Lactose monohydrate: new trials by email Literature Review of Lactose monohydrate trials Research Report on Lactose monohydrate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)
Zenpep, Placebo - Malnutrition
Not applicableRecruitingPhilipp Schuetz202025-09-222026-09-22
Amantadine for COVID-19
Amantadine, Lactose monohydrate - Covid19
Phase 3UnknownCopenhagen University Hospital, Hvidovre2262021-06-012021-10-06
Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis
Aztreonam lysine, Placebo - Bronchiectasis Adult
Phase 4TerminatedUniversity of Dundee342019-10-192026-01-12
Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment
Letrozole, Placebo - Infertility
Phase 2 / Phase 3CompletedSven O. Skouby1292017-02-012019-07-08
Mapping the Endocrine Determinants of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles
Placebo, Letrozole - Infertility
Phase 2 / Phase 3CompletedSven O. Skouby332016-08-012019-02-05
Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder
Minocycline, Placebo, Celecoxib - Major Depressive Disorder
Early Phase 1CompletedCentre for Addiction and Mental Health1152015-02-012019-05-23
Prucalopride Versus Placebo in Gastroparesis
Prucalopride, Placebo - Gastroparesis, Diabetes Mellitus
Phase 2 / Phase 3CompletedUniversity of Calgary152014-03-012020-10-08
Fenobam on Heat/Capsaicin Induced Hyperalgesia in Healthy Volunteers
Fenobam, Placebo - Hyperalgesia, Allodynia
Phase 1CompletedLaura Cavallone332014-01-012016-04-29
Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen.
Losmapimod, Placebo - Chronic Obstructive Pulmonary Disease
Phase 2CompletedCambridge University Hospitals NHS Foundation Trust722012-06-012015-03-17
Intracranial Pressure in Experimental Models of Headache
Acetazolamide, Lactose monohydrate - High Altitude Headache
Not applicableCompletedBangor University232011-07-012012-02-07
Rhodiola Rosea Therapy of Major Depressive Disorder
Herbal extract, Sertraline, Lactose monohydrate - Depression
Phase 3CompletedUniversity of Pennsylvania582010-06-012018-02-22
Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis
Silymarin, Lactose monohydrate - Acute Hepatitis A, Acute Hepatitis B
Phase 2 / Phase 3TerminatedUniversity of Maryland, Baltimore702008-10-012021-04-23
Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)
Tranilast, Placebo comparator - Rheumatoid Arthritis
Phase 1WithdrawnImperial College London2008-09-012015-05-28

Conditions studied

Infertility (2)  ·  Arthritis, Rheumatoid (1)  ·  Atherosclerosis (1)  ·  Bronchiectasis (1)  ·  COVID-19 (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Diabetes Mellitus (1)  ·  Gastroparesis (1)  ·  Hepatitis (1)  ·  Hyperalgesia (1)  ·  Hypoxia (1)  ·  Malnutrition (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Sven O. Skouby (2)  ·  Bangor University (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Centre for Addiction and Mental Health (1)  ·  Copenhagen University Hospital, Hvidovre (1)  ·  Imperial College London (1)  ·  Laura Cavallone (1)  ·  Philipp Schuetz (1)  ·  University of Calgary (1)  ·  University of Dundee (1)  ·  University of Maryland, Baltimore (1)  ·  University of Pennsylvania (1)

Countries

Denmark (3)  ·  United Kingdom (3)  ·  Canada (2)  ·  United States (2)  ·  Egypt (1)  ·  Switzerland (1)

Top investigators

Sven O. Skouby, Professor (2)  ·  Christopher N Andrews, MD, MSc (1)  ·  George T Strickland, MD, PhD, (1)  ·  James Chalmers, MBChB, MRCP (1)  ·  Jeffrey H Meyer, MD, PhD (1)  ·  Joseph Cheriyan, MD (1)  ·  Jun J. Mao, MD (1)  ·  Justin S Lawley, BSc (1)  ·  Laura F Cavallone, M.D. (1)  ·  Michael Polkey, MD (1)  ·  Mohamed Hashem, MD (1)  ·  Nina M Weis, PhD (1)  ·  Peter C Taylor, PhD (1)  ·  Philipp Schuetz, Prof. MD (1)  ·  Samer El-Kamary, MD, MPH (1)

Results publications

PMID 34792133, PMID 37699851, PMID 22994519, PMID 25837277, PMID 35356508, PMID 35652260

NIH funding

2015 (2), 2018 (1), R21AT005230 (1)